Tuesday, April 23, 2024 4/23/2024

Achieving enhanced cytosolic delivery and greater efficacy of therapeutic nucleic acids using DNA-surfactant conjugates

Award Number: R35GM138226
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By Issue Date FY or Funding FY:

View Award Abstract

Project Summary The rapidly expanding field of therapeutic nucleic acids (TNAs) has led to an increased urgency in the development of chemical approaches that can broaden their clinical application. In just the last 3 years the US Food and Drug Administration has approved two TNA based drugs that treat diseases that previously had little option for treatment. Despite these recent achievements, many clinical trials involving TNAs result in termination due to limited efficacy, a result that is often attributed to poor delivery owing to the highly polar and charged character of TNAs that limits accessibility to mRNA in the cytosol of cells. Many platforms deliver nucleic acids using nanoparticle-based approaches that are internalized into cells through endocytosis mechanisms. Therefore, a central bottleneck to their effective delivery is escaping endosomal compartments and gaining access to the cytosol. The central vision of my research program is to address these challenges associated with endosomal escape and TNA delivery to the cytosol at the molecular level. We aim to address these challenges through the synthesis of nucleic acid surfactant conjugates that we have recently shown can successfully target mRNA for gene silencing in vitro. As their design is chemically tunable, we aim to systematically assess the role of the surfactant as it relates to the extent of endosomal escape by evaluating the importance of hydrophobic character, net charge and size of the conjugates. We will also develop a new class of fluorescent surfactant probes which can be used to monitored the delivery and stability of the surfactant conjugates as they are trafficked through cells, thereby helping us to quantify the effects changes in the chemical character of the conjugates have on cytosolic delivery. In conjunction with these studies we will determine the net effect of chemically modifying the nucleic acid surfactant conjugates on the efficacy of gene knockdown in vitro using DNAzymes that result in mRNA cleavage. By controlling the molecular design of individual DNAzyme-surfactant conjugates we can better understand their mechanism of cellular entry and the properties that lead to cytosolic access. Through successful realization of our program we will not only contribute to our understanding of the properties that are necessary for nucleic acids to successfully gain access to the cytosol of cells but also design a platform that will have immediate therapeutic value suitable for future translational applications.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $402,500 )
2023	2023	UNIVERSITY OF CONNECTICUT	438 WHITNEY RD EXTENSION UNIT 1133	STORRS	CT	06269	TOLLAND	USA	Biomedical Research and Research Training	000	4	7/18/2023	NON-COMPETING CONTINUATION	$402,500
														Subtotal = $402,500

Issue Date FY: 2022 ( Subtotal = $402,500 )
2022	2022	UNIVERSITY OF CONNECTICUT	438 WHITNEY RD EXTENSION UNIT 1133	STORRS	CT	06269	TOLLAND	USA	Biomedical Research and Research Training	000	3	7/12/2022	NON-COMPETING CONTINUATION	$402,500
														Subtotal = $402,500

Issue Date FY: 2021 ( Subtotal = $402,500 )
2021	2021	UNIVERSITY OF CONNECTICUT	438 WHITNEY RD EXTENSION UNIT 1133	STORRS	CT	06269	TOLLAND	USA	Biomedical Research and Research Training	000	2	7/30/2021	NON-COMPETING CONTINUATION	$402,500
														Subtotal = $402,500

Issue Date FY: 2020 ( Subtotal = $390,300 )
2020	2020	UNIVERSITY OF CONNECTICUT	438 WHITNEY RD EXTENSION UNIT 1133	STORRS	CT	06269	TOLLAND	USA	Biomedical Research and Research Training	000	1	7/27/2020	NEW	$390,300
														Subtotal = $390,300

Grand Total All Awards = $1,597,800

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Achieving enhanced cytosolic delivery and greater efficacy of therapeutic nucleic acids using DNA-surfactant conjugates

Award Number: R35GM138226

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer